ASIA PACIFIC PULMONARY DRUG DELIVERY MARKET FORECAST 2019-2028
[vc_row][vc_column width=”3/4″][vc_message]The Asia Pacific pulmonary drug delivery market is anticipated to grow with a CAGR of 6.50%, during the forecast period of 2019 to 2028. The high prevalence of chronic obstructive pulmonary disease (COPD) and the increasing number of asthmatic and allergic rhinitis patients are attributed to the region’s market growth. The Asia Pacific pulmonary…




